Wild ride by US-listed China stocks: Reasons go beyond delisting concerns
Rising interest rates, the companies' uninspiring operational performance among reasons investors should not rush to jump in yet
THIS past week, China proposed revisions to its rules related to offshore listings that seem to address a longstanding impasse with the United States over the inspection of audits of Chinese companies listed on American exchanges.
Some market watchers are hopeful that the move will head off a potential mass delisting of Chinese companies in the US, and reduce the enormous volatility that has engulfed many once-high-flying Chinese stocks.
Last month, Chinese stocks gyrated wildly after the US Securities and Exchange Commission (SEC) named five companies - BeiGene, Yum China, Zai Lab, ACM Research and Hutchmed (China) - that could be delisted from American exchanges as a result of the US authorities being unable to inspect their audits as required under the Holding Foreign Companies Accountable Act.
TRENDING NOW
CSE Global independent director quits after clashes with chairman Eugene Lai over board refresh
Cat A COE rate exceeds Cat B for third time in 4 months; premiums largely down
What’s wrong with Orchard Road? Experts weigh in on the street’s cachet and its future
Singapore workers experiencing rising anxiety; signs of fallout from pressure to use AI